Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mizuho Inazu is active.

Publication


Featured researches published by Mizuho Inazu.


Journal of Bone and Mineral Research | 1998

Responses of trabecular and cortical bone turnover and bone mass and strength to bisphosphonate YH529 in ovariohysterectomized beagles with calcium restriction

Yasushi Yoshida; Atsuko Moriya; Kazuyuki Kitamura; Mizuho Inazu; Nobukazu Okimoto; Yuichi Okazaki; Toshitaka Nakamura

Thirty‐six beagles, 18 months of age, underwent ovariohysterectomy (OHX) or a sham operation. Sham‐operated animals were given a diet with standard calcium (1.4%) (group 1, n = 6) or a restricted calcium diet (0.14%) (group 2, n = 6). The OHX animals were given the restricted calcium diet and YH529 orally with respective daily doses of 0, 0.02, 0.1, and 0.5 mg/kg of body weight (groups 3–6, n = 6 each) for 12 months. At the end of this period, the lumbar bone mineral densities (BMDs) in groups 2 and 3 and the load values for group 3 were significantly smaller than those for group 1. The midfemur BMD did not differ among the groups. The urinary deoxypyridinoline (U‐Dpy) and bone formation rates (BFR/BS, BFR/BV) in groups 2 and 3 and the osteonal BFR/BS and trabecular osteoclast number (Oc.N/BS) in group 3 were significantly larger than the respective values for group 1. However, these parameters did not significantly differ between groups 2 and 3. The serum osteocalcin (OC) level, wall thickness (W.Th), and mineral apposition rate values for group 3 were significantly larger than those for group 2. In group 2, the trabecular activation frequency (Ac.F) increased by 3.11 times, and the percent values of the number of labeled osteons (L‐Ot.N/T‐Ot.N, %) in the tibia by 3.28 times over those for group 1. In group 3, the Ac.F increased by 3.20 times and the number of labeled osteons by 3.77 times over those for group 1. In groups 4–6, the U‐Dpy and Oc.N/BS values were smaller, but their OC levels did not significantly differ from the level for group 3. The lumbar BMD, the load, and W.Th were dose‐dependently significantly larger than those for group 3. The Ac.F values were significantly smaller, and the respective value in groups 4–6 was 67.9, 25.5, and 10.2% of that in group 3. The BMDs of the midfemur in groups 4–6 were significantly larger than those in group 3, but the ultimate load values did not significantly differ. The L‐Ot.N/T‐Ot.N values were also significantly smaller, and the respective value in groups 4–6 was 82.0, 48.5, and 55.2% of that in group 3. The tibial endocortical and periosteal BFR/BSs did not differ significantly. These data demonstrate that the effects of OHX on bone mass and turnover were small in the beagles fed a restricted calcium diet. YH529 maintained the mass and strength of the lumbar bone by reducing the bone resorption. The cortical bone appeared to be less sensitive to the agent than the trabecular bone in this animal model.


Archive | 1994

Use of synthetic retinoids for osteopathy.

Koichi Shudo; Tatsuo Sugioka; Mizuho Inazu; Hideyuki Tanaka; Tsutomu Inoue; Kazuyuki Kitamura


Archive | 1996

Agents for promoting bone formation

Kazuyuki Kitamura; Osamu Komiyama; Mizuho Inazu; Roland Baron; Thomas Richard Gadek; Jochen Knolle; Hans-Ulrich Stilz; Volkmar Wehner; Robert McDowell


Archive | 1994

Method of treating bone disease with pyridine, carboxamide and carboxylic derivatives

Koichi Shudo; Tatsuo Sugioka; Mizuho Inazu; Hideyuki Tanaka; Tsutomu Inoue; Kazuyuki Kitamura


Archive | 1995

Anti-osteopathic composition

Koichi Shudo; Tatsuo Sugioka; Mizuho Inazu; Hideyuki Tanaka; Tsutomu Inoue; Kazuyuki Kitamura


Archive | 1997

Imidobisphosphoric acids, and use therefor

Christoph Naumann; Katsuhiro Yoshikawa; Kazuyuki Kitamura; Mizuho Inazu


Archive | 1996

Mittel zur förderung von knochenbildung Means for promotion of bone formation

Roland Baron; Thomas Oakland Gadek; Mizuho Inazu; Kazuyuki Kitamura; Jochen Knolle; Osamu Komiyama; Robert Mcdowell; Han-Ulrich Stilz; Volkmar Wehner


Archive | 1996

Means for promotion of bone formation

Roland Baron; Thomas Oakland Gadek; Mizuho Inazu; Kazuyuki Kitamura; Jochen Knolle; Osamu Komiyama; Robert Mcdowell; Han-Ulrich Stilz; Volkmar Wehner


Archive | 1995

Imidobisphosphoric acid, its production and use thereof

Mizuho Inazu; Kazuyuki Kitamura; Christoph Naumann; Katsuhiro Yoshikawa; クリストフ・ナウマン; 和之 北村; 雄裕 吉川; 水穂 稲津


Archive | 1995

Imidobisphosphorsyrer, process for their preparation and use thereof

Christoph Naumann; Katsuhiro Yoshikawa; Kazuyuki Kitamura; Mizuho Inazu

Collaboration


Dive into the Mizuho Inazu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge